body

LORBRENA is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene, and that has spread to other parts of your body (metastatic).


Your healthcare provider will perform a test to make sure that LORBRENA is right for you.


It is not known if LORBRENA is safe and effective in children.

name
dismiss
true
showMore
Show more
showLess
Show less
eyebrow
Meet Grace, a LORBRENA patient.
headline

Grace is living with stage IV ALK+ lung cancer

headline2
content
buttons
Watch her story
image
Meet Grace
Mobile_image
Image-caption
Patient was compensated for her time.
eyebrow
Meet Stephen, a LORBRENA patient.
headline

Stephen is living with stage IV ALK+ lung cancer

headline2
content
Started LORBRENA after having tumor growth on his first therapy.
buttons
Watch his story
image
Stephan banner
Mobile_image
Image-caption
Patient was compensated for his time.
content
LORBRENA is a once-daily oral prescription medicine for adults with anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic).
disclaimer
icon
headline

LORBRENA helped people live longer without their ALK+ mNSCLC further growing or spreading (compared to crizotinib)

content
In a clinical trial involving LORBRENA and crizotinib, more than half of the patients taking LORBRENA were still alive and had not experienced cancer growth or spread at the analysis with 18 months of follow-up. Therefore, the median* progression-free survival for LORBRENA had not been reached yet. Patients taking crizotinib experienced cancer progression at a median of 9 months. More time is needed to find out if patients taking LORBRENA live longer than patients taking crizotinib. See safety information.
disclaimer
*A statistical term. A median is the middle value in a set of measurements.
Buttons
Learn more about the study
headline
headline2
content
eyebrow
disclaimer
†Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico.
card_identifier
heading

Starting LORBRENA?

body
Learn about treatment with LORBRENA, including possible side effects and how to work with your doctor to help manage them.
cta
See what to expect
card_identifier
heading

Financial assistance

body
Eligible, commercially insured patients may pay as little as $0 per month for their Pfizer Oncology treatment. Limits, terms, and conditions apply.† Patients may receive up to $10,600 per product in savings annually.
cta
Learn more
icon
headline

Taking LORBRENA?

subheadline
content
If your doctor prescribed LORBRENA, you can receive information and resources to help you navigate treatment.
disclaimer
buttons
Sign up
card_identifier
pot logo
Mobile_image
pot logo
heading
body

Turn to Pfizer Oncology Together for financial assistance resources and personalized support.

Call 1-877-744-5675 (Monday-Friday 8 AM-8 PM ET)

cta
Visit PfizerOncologyTogether.com